Rede?ning Management of Hematological Disorders in 2021& beyond

Part 1 - Welcome note & context setting - Dr. M B Agarwal, Mumbai

Part 2 - Treatment of pediatric severe acquired aplastic anaemia with ACE therapy - Dr. M B Agarwal

Part 3 - Immune pro?ling in multiple myeloma - Dr. Aditya Murali, Bengaluru

Part 4 - Managing myeloma: Where we are, where we're going and where we should be going- Dr. Padmaja

Part 5 - Panel discussion: Daratumumab based therapies in transplant eligibleNDMM (D-VTd & D-VRd)

Part 6 - Daratumumab based therapies in transplant-ineligible NDMM (D-VMP & Drd)

Part 7 - Indian context - Deep & Durable response - Dr. Rahul Bhargava

Part 8 - Concluding remarks - Dr. M B Agarwal, Mumbai